Old Dominion Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$405K Sell
4,955
-11
-0.2% -$990 0.09% 134
2021
Q2
$453K Buy
4,966
+178
+4% +$15.9K 0.1% 124
2021
Q1
$409K Buy
4,788
+484
+11% +$43.4K 0.1% 122
2020
Q4
$406K Buy
4,304
+230
+6% +$20.1K 0.1% 123
2020
Q3
$354K Sell
4,074
-3
-0.1% -$260 0.1% 118
2020
Q2
$356K Buy
4,077
+1,399
+52% +$121K 0.11% 116
2020
Q1
$221K Sell
2,678
-44
-2% -$3.93K 0.09% 129
2019
Q4
$258K Buy
2,722
+30
+1% +$2.69K 0.08% 133
2019
Q3
$234K Buy
2,692
+398
+17% +$35.7K 0.08% 133
2019
Q2
$209K Buy
+2,294
New +$194K 0.07% 131

Other funds holding NVS

Old Dominion Capital Management's NVS Position: Q3 2021 in Review

Old Dominion Capital Management reduced its Novartis (NVS) stake by 0.22% in Q3 2021, selling an estimated $990 and leaving 4,955 shares worth $405K. The position accounts for 0.09% of the portfolio, ranked #134.

Old Dominion Capital Management first reported a position in NVS in Q2 2019 and has held it in 10 quarters since. The position peaked at $453K in Q2 2021. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • Old Dominion Capital Management held 4,955 shares of Novartis worth $405K as of Q3 2021.
  • Old Dominion Capital Management sold 11 Novartis shares in Q3 2021, an estimated $990.
  • Novartis made up 0.09% of Old Dominion Capital Management's portfolio in Q3 2021, its #134 holding.
  • Old Dominion Capital Management first reported a position in Novartis in Q2 2019 and has held it in 10 quarters since.
  • Old Dominion Capital Management's Novartis position peaked at $453K in Q2 2021.
  • 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.